Drugs Archives - Page 41 of 67

KHN’s ‘What The Health’: Politics Heading Into 2020: Live From Aspen!

How big an issue will health really be in the 2020 election? Will the Republicans find their political footing on the issue? In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Margot Sanger-Katz of The New York Times report from the Aspen Ideas: Health festival in Aspen, Colo. Joining them are Chris Jennings, who advised Democratic Presidents Bill Clinton and Barack Obama on health policy, and Lanhee Chen, who advised GOP presidential candidates Mitt Romney and Marco Rubio.

June 24, 2019

Non-English Speakers Face Health Setback If Trump Loosens Language Rules

A rule proposed by the Trump administration would leave patients with limited English proficiency with fewer guarantees of a written notice that free translation services are available. It also would no longer require directions on how patients can report discrimination they experience in a medical setting.

By Carmen Heredia Rodriguez

June 24, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

June 21, 2019

Investigation

Surgeons’ Opioid-Prescribing Habits Are Hard To Kick

A new data analysis by KHN and Johns Hopkins researchers shows that even as the CDC issued warnings, surgeons handed out many times the number of opioid pills needed for post-op pain.

By Julie Appleby and Elizabeth Lucas

June 21, 2019

Investigation

Opioid Operators: How Surgeons Ply Patients With Painkillers

Even as awareness of the opioid crisis grew, prescribing habits of surgeons changed very little from 2011 to 2016, found a data analysis by KHN and Johns Hopkins Bloomberg School of Public Health. Use this interactive tool to search by doctor or practicing hospital.

By Elizabeth Lucas

June 20, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

June 14, 2019

FDA Overlooked Red Flags In Drugmaker’s Testing of New Depression Medicine

In March, a chemical cousin of the anesthetic and club drug ketamine was approved for the treatment of patients with intractable depression. But critics say studies presented to the FDA provided at best modest evidence it worked and did not include information about the safety of the drug, Spravato, for long-term use.

By Emmarie Huetteman

June 11, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

June 7, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

May 31, 2019

Oklahoma’s ‘Precedent-Setting’ Suit Puts Opioid Drugmakers On Trial

As states struggle to respond to the national drug crisis, officials around the country are watching Oklahoma. The state's attorney general says opioid drugmakers helped ignite a health crisis that has killed thousands of residents.

By Jackie Fortiér, StateImpact Oklahoma

May 28, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

May 24, 2019

Why Missouri’s The Last Holdout On A Statewide Rx Monitoring Program

For the seventh year in a row, Missouri will retain its lonely title as the only state without a statewide prescription drug monitoring program. Fears about privacy violations and gun control scuttled the bill yet again, leaving a pastiche of half-step measures in place to fill the void in the fight against prescription drug abuse.

By Lauren Weber

May 20, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

May 17, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

May 10, 2019

Podcast: KHN’s ‘What The Health?’ ‘Conscience’ Rules, Rx Prices and Still More Medicare

Joanne Kenen of Politico, Jen Haberkorn of the Los Angeles Times and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss the latest news about the Trump administration’s effort to allow health care practitioners and organizations to refuse to provide care or refer patients for services that violate their conscience or religion. Also this week, the administration orders TV ads for prescription drugs to include list prices. And Tennessee wants free rein from the federal government to run its Medicaid program. Plus, Rovner interviews Joan Biskupic, author of a new book on Chief Justice John Roberts, about the behind-the-scenes negotiations that led to the 2012 ruling upholding the constitutionality of the Affordable Care Act.

May 9, 2019

Price Check On Drug Ads: Would Revealing Costs Help Patients Control Spending?

As part of his plan to tamp down drug pricing, President Donald Trump wants pharmaceutical companies to provide cost information in drug ads — just like side effects.

By Julie Appleby and Sydney Lupkin

May 9, 2019

Addiction Medicine Mostly Prescribed To Whites, Even As Opioid Deaths Rose Among Blacks

A study looked at who gets Suboxone prescriptions and found that whites are almost 35 times more likely to get the addiction treatment than African Americans.

By Martha Bebinger

May 8, 2019

The Money And Politics Of Prescription Drugs: What You Need To Know

America spends about as much on prescription drugs as all the revenues of the three big car makers combined. Tracking where the money goes is hard. PolitiFact has some charts to help.

By Jon Greenberg, PolitiFact

May 8, 2019